JS212 in Combination With JS111 as First-Line Treatment in EGFR-Mutant Advanced NSCLC
JS212 in Combination With JS111 as First-Line Treatment in EGFR-Mutant Advanced NSCLC
Not yet recruiting · NCT07714304 · Registry updated 2026-07-20Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| JS212 in Combination With JS111 as First-Line Treatment in EGFR-Mutant Advanced NSCLC | NSCLC Harboring EGFR Mutations | Not yet recruiting | Not applicable | 2026-07-20 | NCT07714304 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Huan Zhou | 1 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Shanghai Chest Hospital | Shanghai | China | 83 |
| The First Affiliated Hospital of Anhui Medical University | Hefei | China | 4 |